U.S. federal trademark · Serial No. 79378210 · Reg. No. 7616796
Research services and development in the fields of organ transplantation, ischemia-reperfusion injury, thromboinflammation, rejection of organs, organ or cell transplant rejection, hyperacute rejection of organs, antibody-mediated rejection of organs and organ tissue damage
Chemical preparations for medical or veterinary purposes, namely, pharmaceutical preparations used for the treatment of blood supply flow disorders, transfusion and infusion of blood components, inflammation, thrombosis, blood clotting disorders, instant blood mediated reaction (IBMIR), stroke, myocardial infarction, immunosuppressant disorders and immune system rejection; chemical preparations for medical and veterinary purposes, namely, for treatment of cells, cell transplants and organ transplants; chemical preparations for medical and veterinary purposes, namely protecting organs from damage in connection with transplantation, for reducing ischemia-reperfusion injury, for protection of ischemic cells against attacks by the immune system, for protecting the peritoneum in connection with dialyses and for reduction of the risk of or protection against thromboinflammation, rejection of organs, organ or cell transplant rejection, hyperacute rejection of organs, and antibody-mediated rejection of organs
Medical services, information and consultancy in the fields of organ transplantation, ischemia-reperfusion injury, thromboinflammation, rejection of organs, organ or cell transplant rejection, hyperacute rejection of organs, antibody-mediated rejection of organs and organ tissue damage
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.